Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PITAVASTATIN vs SIMVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PITAVASTATIN vs SIMVASTATIN: Safety Overview

Metric PITAVASTATIN SIMVASTATIN
Total FAERS Reports 2,344 27,079
Deaths Reported 346 2,792
Death Rate 14.8% 10.3%
Hospitalizations 351 8,824
Average Patient Age 65.1 yrs 66.6 yrs
% Female Patients 56.0% 47.5%
FDA Approval Date Apr 30, 2024 Apr 14, 2009
Manufacturer Aurobindo Pharma Limited Aphena Pharma Solutions - Tennessee, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription